Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.52 |
| ▸ | THRB | P10828 | 2/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 5/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4970329 | 0.91 | KDM4C (0.45) | KDM4CCYP2C19CYP3A4ALDH1A1THRB | |
| SCHEMBL4968554 | 0.88 | TSHR (0.47) | KDM4CCYP2C19CYP3A4ALDH1A1THRB | |
| SCHEMBL4968541 | 0.87 | KDM4C (0.54) | KDM4CCYP2C19CYP3A4ALDH1A1THRB | |
| SCHEMBL4970321 | 0.86 | MEN1 (0.50) | KDM4CCYP2C19CYP3A4ALDH1A1MEN1 | |
| SCHEMBL4969050 | 0.86 | KDM4C (0.41) | KDM4CCYP2C19CYP3A4ALDH1A1THRB | |
| SCHEMBL4968565 | 0.85 | KDM4C (0.41) | KDM4CCYP2C19CYP3A4ALDH1A1THRB | |
| SCHEMBL4968509 | 0.84 | KDM4C (0.41) | KDM4CCYP2C19CYP3A4ALDH1A1THRB | |
| SCHEMBL4971988 | 0.84 | KDM4C (0.41) | KDM4CCYP2C19CYP3A4ALDH1A1THRB | |
| SCHEMBL4968506 | 0.84 | KDM4C (0.41) | KDM4CCYP2C19CYP3A4ALDH1A1THRB | |
| SCHEMBL4970236 | 0.84 | KMT2A (0.40) | KDM4CCYP2C19CYP3A4ALDH1A1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1985297-A1 | CARBOXYLIC ACID COMPOUND AND USE THEREOF | Japan Tobacco, Inc. (JP) | 2008-10-29 | — | — | EP | disclosed |
| US-20070197512-A1 | Carboxylic Acid Compounds and Use Thereof | JAPAN TOBACCO INC. (JP) | 2007-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070197512-A1 | Carboxylic Acid Compounds and Use Thereof | GLS, SLC10A1, SOAT1 | KDM4C 2123/4885CYP2C19 1884/4885CYP3A4 3089/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.